Geoffrey Shapiro

77PUBLICATIONS
666CO-AUTHORS
Molecular targetsEvolutionary computationHaematological tumoursRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (77)

|Oct 07, 2026
PARP1-selective inhibitor DSB1559 demonstrates superior efficacy and antitumor immunity in triple-negative breast cancer.

|Sep 24, 2026
TALAVE in Breast Cancer: BRCA1/2 Mutation-Dependent Immune Remodeling after PARP Inhibition with Limited Checkpoint Engagement.

|Sep 02, 2026
AI-enhanced adaptive virtual screening of large libraries for ligand discovery.

|Aug 24, 2026
A Phase II Study of Berzosertib in Combination with Carboplatin Compared with Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer.

|Aug 14, 2026
Defective microhomology-mediated end joining in SMARCB1-deficient tumors.

|Jul 13, 2026
Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial.

Pageof 13

Frequent Collaborators

20 joint publications

Alan D'Andrea

9 joint publications

Bose S Kochupurakkal

8 joint publications

Christopher A French

7 joint publications

James M Cleary